T1	Age 2 13	66-year-old
T2	Personal_background 14 23	Caucasian
T3	Sex 24 29	woman
T4	History 48 60	hypertension
T5	Sign_symptom 48 60	hypertension
E1	Sign_symptom:T5 
T6	Clinical_event 65 73	admitted
E2	Clinical_event:T6 
T7	Nonbiological_location 81 89	hospital
R1	MODIFY Arg1:T7 Arg2:E2	
T8	Disease_disorder 117 133	Burkitt lymphoma
E3	Disease_disorder:T8 
T9	Diagnostic_procedure 139 160	lactate dehydrogenase
E4	Diagnostic_procedure:T9 
T10	Qualitative_concept 171 175	high
R2	MODIFY Arg1:T10 Arg2:E4	
T11	Sign_symptom 212 216	mass
E5	Sign_symptom:T11 
T12	Biological_structure 200 211	mediastinal
R3	MODIFY Arg1:T12 Arg2:E5	
T13	Distance 221 235	more than 10cm
R4	MODIFY Arg1:T13 Arg2:E5	
T14	Diagnostic_procedure 241 261	physical examination
E6	Diagnostic_procedure:T14 
T16	Diagnostic_procedure 284 303	electrocardiography
E7	Diagnostic_procedure:T16 
T17	Diagnostic_procedure 305 308	ECG
E8	Diagnostic_procedure:T17 
R6	IDENTICAL Arg1:E8 Arg2:E7	
T18	Detailed_description 278 283	basal
R7	MODIFY Arg1:T18 Arg2:E7	
T19	Sign_symptom 317 329	sinus rhythm
E9	Sign_symptom:T19 
T20	Diagnostic_procedure 337 347	heart rate
E10	Diagnostic_procedure:T20 
T21	Lab_value 351 366	72 beats/minute
R8	MODIFY Arg1:T21 Arg2:E10	
T22	Diagnostic_procedure 368 414	Two-dimensional transthoracic echocardiography
E11	Diagnostic_procedure:T22 
T23	Diagnostic_procedure 416 419	TTE
E12	Diagnostic_procedure:T23 
R9	IDENTICAL Arg1:E12 Arg2:E11	
T24	Detailed_description 421 428	Siemens
T25	Detailed_description 430 444	Acuson Sequoia
T26	Detailed_description 446 450	C512
R10	MODIFY Arg1:T24 Arg2:E11	
R11	MODIFY Arg1:T25 Arg2:E11	
R12	MODIFY Arg1:T26 Arg2:E11	
T27	Diagnostic_procedure 468 491	biventricular functions
E13	Diagnostic_procedure:T27 
T29	Diagnostic_procedure 500 520	LV ejection fraction
E14	Diagnostic_procedure:T29 
T30	Diagnostic_procedure 522 526	LVEF
E15	Diagnostic_procedure:T30 
R14	IDENTICAL Arg1:E15 Arg2:E14	
T31	Lab_value 531 534	60%
R15	MODIFY Arg1:T31 Arg2:E14	
T32	Sign_symptom 562 575	regurgitation
E16	Sign_symptom:T32 
T33	Biological_structure 552 561	tricuspid
T34	Biological_structure 541 547	mitral
T35	Severity 536 540	mild
R16	MODIFY Arg1:T35 Arg2:E16	
R17	MODIFY Arg1:T34 Arg2:E16	
R18	MODIFY Arg1:T33 Arg2:E16	
T36	Sign_symptom 590 610	pericardial effusion
E17	Sign_symptom:T36 
T37	Severity 581 589	moderate
R19	MODIFY Arg1:T37 Arg2:E17	
T38	Diagnostic_procedure 614 629	risk assessment
E18	Diagnostic_procedure:T38 
T39	Qualitative_concept 660 669	high-risk
R20	MODIFY Arg1:T39 Arg2:E18	
T40	Medication 697 779	rituximab-hyperfractionated-cyclophosphamide-vincristine-doxorubicin-dexamethasone
E19	Medication:T40 
T41	Medication 781 793	R-Hyper-CVAD
E20	Medication:T41 
R21	IDENTICAL Arg1:E20 Arg2:E19	
T42	Medication 795 807	chemotherapy
E21	Medication:T42 
R22	SUB_PROCEDURE Arg1:E19 Arg2:E21	
T43	Diagnostic_procedure 822 839	laboratory values
E22	Diagnostic_procedure:T43 
T44	Medication 890 906	cyclophosphamide
E23	Medication:T44 
T45	Dosage 880 889	high-dose
R23	MODIFY Arg1:T45 Arg2:E23	
T46	Dosage 907 927	300mg/m2 twice daily
T47	Duration 932 938	3 days
E24	Duration:T47 
R24	MODIFY Arg1:T46 Arg2:E23	
T48	Medication 940 951	doxorubicin
E25	Medication:T48 
T49	Dosage 952 963	25mg/m2/day
R25	MODIFY Arg1:T49 Arg2:E25	
T50	Duration 968 974	2 days
E26	Duration:T50 
T51	Medication 976 985	rituximab
E27	Medication:T51 
T52	Dosage 986 998	375mg/m2/day
R26	MODIFY Arg1:T52 Arg2:E27	
T53	Duration 1003 1008	1 day
E28	Duration:T53 
T54	Medication 1010 1023	dexamethasone
E29	Medication:T54 
T55	Dosage 1024 1032	40mg/day
R27	MODIFY Arg1:T55 Arg2:E29	
T56	Duration 1037 1043	4 days
E30	Duration:T56 
T57	Medication 1049 1060	vincristine
E31	Medication:T57 
T58	Sign_symptom 2733 2744	neutropenia
E32	Sign_symptom:T58 
T59	Disease_disorder 2749 2758	pneumonia
E33	Disease_disorder:T59 
T60	Sign_symptom 2771 2795	cardiac failure symptoms
E34	Sign_symptom:T60 
A1	POLARITY E34 NEG
T61	Medication 2808 2820	chemotherapy
E35	Medication:T61 
T62	Medication 2864 2876	chemotherapy
E36	Medication:T62 
A2	POLARITY E36 NEG
T63	Detailed_description 2846 2860	another course
R28	MODIFY Arg1:T63 Arg2:E36	
T64	Sign_symptom 2894 2903	remission
E37	Sign_symptom:T64 
T65	Medication 2621 2633	R-Hyper-CVAD
E38	Medication:T65 
T66	Medication 2634 2646	chemotherapy
E39	Medication:T66 
R29	SUB_PROCEDURE Arg1:E38 Arg2:E39	
T67	Medication 2683 2695	methotrexate
E40	Medication:T67 
T68	Medication 2700 2710	cytarabine
E41	Medication:T68 
T69	Dosage 2673 2682	high-dose
R30	MODIFY Arg1:T69 Arg2:E40	
T70	Sign_symptom 2461 2468	dyspnea
E42	Sign_symptom:T70 
A3	TREND E42 DEC
T71	Activity 2491 2501	discharged
E43	Activity:T71 
T72	Date 2505 2511	day 20
E44	Date:T72 
T73	Date 2513 2526	After 1 month
E45	Date:T73 
T74	Diagnostic_procedure 2528 2531	TTE
E46	Diagnostic_procedure:T74 
T75	Diagnostic_procedure 2546 2569	biventricular functions
E47	Diagnostic_procedure:T75 
T77	Diagnostic_procedure 2578 2582	LVEF
E48	Diagnostic_procedure:T77 
T78	Lab_value 2586 2589	60%
R32	MODIFY Arg1:T78 Arg2:E48	
T79	Dosage 1061 1068	2mg/day
T80	Duration 1073 1079	2 days
E49	Duration:T80 
R33	MODIFY Arg1:T79 Arg2:E31	
T81	Sign_symptom 1584 1591	dyspnea
E50	Sign_symptom:T81 
T82	Date 1599 1610	seventh day
E51	Date:T82 
T83	Diagnostic_procedure 1625 1645	physical examination
E52	Diagnostic_procedure:T83 
T84	Diagnostic_procedure 2405 2409	LVEF
E53	Diagnostic_procedure:T84 
T85	Diagnostic_procedure 2391 2394	TTE
E54	Diagnostic_procedure:T85 
T86	Date 2376 2389	After 12 days
E55	Date:T86 
T87	Lab_value 2413 2416	37%
E56	Lab_value:T87 
R34	MODIFY Arg1:E56 Arg2:E53	
T88	Diagnostic_procedure 2428 2455	right ventricular functions
E57	Diagnostic_procedure:T88 
T89	Lab_value 2421 2427	normal
E58	Lab_value:T89 
R35	MODIFY Arg1:E58 Arg2:E57	
T90	Disease_disorder 2222 2233	myocarditis
E59	Disease_disorder:T90 
A4	POLARITY E59 UNCERTAIN
T91	Disease_disorder 2193 2220	Drug-induced cardiotoxicity
E60	Disease_disorder:T91 
A5	POLARITY E60 UNCERTAIN
T92	Medication 2938 2950	chemotherapy
E61	Medication:T92 
T93	Medication 1109 1125	cyclophosphamide
E62	Medication:T93 
T94	Medication 1130 1141	doxorubicin
E63	Medication:T94 
T95	Dosage 1155 1164	1800mg/m2
T96	Dosage 1169 1176	50mg/m2
R36	MODIFY Arg1:T95 Arg2:E62	
R37	MODIFY Arg1:T96 Arg2:E63	
T97	Medication 1206 1217	allopurinol
E64	Medication:T97 
T98	Dosage 1218 1227	300mg/day
T99	Administration 1228 1237	perorally
R38	MODIFY Arg1:T98 Arg2:E64	
R39	MODIFY Arg1:T99 Arg2:E64	
T100	Medication 1239 1257	sodium bicarbonate
E65	Medication:T100 
T101	Dosage 1259 1263	8.4%
T102	Dosage 1265 1278	10 flacon/day
R40	MODIFY Arg1:T101 Arg2:E65	
R41	MODIFY Arg1:T102 Arg2:E65	
T103	Medication 1309 1321	chemotherapy
E66	Medication:T103 
T104	Administration 1280 1288	infusion
R42	MODIFY Arg1:T104 Arg2:E65	
T105	Duration 1293 1308	24 hours before
E67	Duration:T105 
T106	Medication 1327 1332	mesna
E68	Medication:T106 
T107	Dosage 1333 1345	600mg/m2/day
R43	MODIFY Arg1:T107 Arg2:E68	
T108	Duration 1350 1356	2 days
E69	Duration:T108 
T109	Disease_disorder 1380 1400	tumor lysis syndrome
E70	Disease_disorder:T109 
A6	POLARITY E70 UNCERTAIN
T110	Disease_disorder 1405 1425	hemorrhagic cystitis
E71	Disease_disorder:T110 
A7	POLARITY E71 UNCERTAIN
T111	Therapeutic_procedure 1360 1371	prophylaxis
E72	Therapeutic_procedure:T111 
T112	Medication 1459 1470	granisetron
E73	Medication:T112 
T113	Dosage 1471 1478	2mg/day
R44	MODIFY Arg1:T113 Arg2:E73	
T114	Medication 1483 1495	lansoprazole
E74	Medication:T114 
R45	SUB_PROCEDURE Arg1:E68 Arg2:E72	
T115	Dosage 1496 1504	30mg/day
R46	MODIFY Arg1:T115 Arg2:E74	
T116	Therapeutic_procedure 1535 1546	prophylaxis
E75	Therapeutic_procedure:T116 
T117	Biological_structure 1527 1534	gastric
T118	Detailed_description 1508 1522	antiemetogenic
R47	MODIFY Arg1:T117 Arg2:E75	
R48	MODIFY Arg1:T118 Arg2:E75	
R49	SUB_PROCEDURE Arg1:E73 Arg2:E75	
R50	SUB_PROCEDURE Arg1:E74 Arg2:E75	
T119	Diagnostic_procedure 1655 1669	blood pressure
E76	Diagnostic_procedure:T119 
T120	Lab_value 1673 1683	100/60mmHg
E77	Lab_value:T120 
T121	Diagnostic_procedure 1690 1700	heart rate
E78	Diagnostic_procedure:T121 
T122	Lab_value 1704 1720	110 beats/minute
E79	Lab_value:T122 
R51	MODIFY Arg1:E77 Arg2:E76	
R52	MODIFY Arg1:E79 Arg2:E78	
T123	Diagnostic_procedure 1731 1743	auscultation
E80	Diagnostic_procedure:T123 
T124	Biological_structure 1725 1730	chest
R53	MODIFY Arg1:T124 Arg2:E80	
T125	Sign_symptom 1797 1817	inspiratory crackles
E81	Sign_symptom:T125 
T126	Sign_symptom 1748 1766	inspiratory sounds
E82	Sign_symptom:T126 
A8	POLARITY E82 NEG
T127	Biological_structure 1781 1792	lower zones
R54	MODIFY Arg1:T127 Arg2:E82	
T128	Biological_structure 1832 1844	middle zones
R55	MODIFY Arg1:T128 Arg2:E81	
T129	Sign_symptom 1874 1876	S3
E83	Sign_symptom:T129 
A9	POLARITY E83 NEG
#1	AnnotatorNotes E83	S3 gallop
T130	Sign_symptom 1854 1869	cardiac murmurs
E84	Sign_symptom:T130 
A10	POLARITY E84 NEG
T131	Diagnostic_procedure 1892 1895	ECG
E85	Diagnostic_procedure:T131 
T132	Lab_value 1903 1914	low voltage
E86	Lab_value:T132 
T133	Diagnostic_procedure 1922 1947	limb and precordial leads
E87	Diagnostic_procedure:T133 
R56	SUB_PROCEDURE Arg1:E87 Arg2:E85	
R57	MODIFY Arg1:E86 Arg2:E87	
T134	Diagnostic_procedure 1949 1952	TTE
E88	Diagnostic_procedure:T134 
T135	Diagnostic_procedure 1991 2003	echogenicity
E89	Diagnostic_procedure:T135 
T136	Biological_structure 1980 1990	myocardial
T137	Lab_value 1960 1979	diffusely increased
E90	Lab_value:T137 
R58	MODIFY Arg1:E90 Arg2:E89	
R59	MODIFY Arg1:T136 Arg2:E89	
T138	Sign_symptom 2010 2030	pericardial effusion
E91	Sign_symptom:T138 
T139	Severity 2005 2009	mild
R60	MODIFY Arg1:T139 Arg2:E91	
T140	Diagnostic_procedure 2069 2087	systolic functions
E92	Diagnostic_procedure:T140 
T141	Detailed_description 2055 2068	biventricular
T142	Lab_value 2036 2054	generally impaired
E93	Lab_value:T142 
R61	MODIFY Arg1:E93 Arg2:E92	
R62	MODIFY Arg1:T141 Arg2:E92	
T143	Diagnostic_procedure 2096 2100	LVEF
E94	Diagnostic_procedure:T143 
T144	Lab_value 2101 2104	31%
E95	Lab_value:T144 
T145	Sign_symptom 2138 2146	akinesis
E96	Sign_symptom:T145 
T146	Biological_structure 2109 2126	right ventricular
T147	Detailed_description 2127 2137	mid-apical
R63	MODIFY Arg1:T147 Arg2:E96	
R64	MODIFY Arg1:T146 Arg2:E96	
R65	MODIFY Arg1:E95 Arg2:E94	
T148	Sign_symptom 2157 2173	pleural effusion
E97	Sign_symptom:T148 
T149	Detailed_description 2148 2156	Manifest
R66	MODIFY Arg1:T149 Arg2:E97	
T150	Medication 2250 2260	Furosemide
E98	Medication:T150 
T151	Medication 2265 2273	ramipril
E99	Medication:T151 
T152	Medication 2292 2304	beta-blocker
E100	Medication:T152 
A11	TREND E100 STAY
T153	Sign_symptom 2348 2360	hypertension
E101	Sign_symptom:T153 
R67	BEFORE Arg1:E1 Arg2:E2	
*	OVERLAP E2 E3 E4 E5 E6 E7 E9 E10 E11 E13 E14 E16 E17 E18
T15	Lab_value 266 272	normal
E102	Lab_value:T15 
R5	MODIFY Arg1:E102 Arg2:E6	
T28	Lab_value 461 467	normal
E103	Lab_value:T28 
R13	MODIFY Arg1:E103 Arg2:E13	
R68	BEFORE Arg1:E18 Arg2:E19	
*	OVERLAP E19 E22 E23 E24 E25 E26 E27 E28 E29 E30 E31 E49 E62 E63 E64 E65 E67 E66 E69 E72 E70 E71 E75
R69	BEFORE Arg1:E75 Arg2:E50	
*	OVERLAP E50 E51 E52 E76 E78 E80 E82 E81 E84 E83 E85 E88 E89 E91 E92 E94 E96 E97 E60 E59
R70	BEFORE Arg1:E59 Arg2:E98	
*	OVERLAP E98 E99 E100 E101
R71	BEFORE Arg1:E101 Arg2:E55	
*	OVERLAP E55 E54 E53 E57 E42
R72	BEFORE Arg1:E42 Arg2:E43	
*	OVERLAP E43 E44
R73	BEFORE Arg1:E44 Arg2:E45	
*	OVERLAP E45 E46 E47 E48 E38
T76	Lab_value 2539 2545	normal
E104	Lab_value:T76 
R31	MODIFY Arg1:E104 Arg2:E47	
R74	BEFORE Arg1:E38 Arg2:E40	
*	OVERLAP E40 E41 E32 E33 E34 E35
R75	BEFORE Arg1:E35 Arg2:E36	
R76	BEFORE Arg1:E36 Arg2:E37	
R77	AFTER Arg1:E37 Arg2:E61	
